TWi Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
TWi Biotechnology has a total shareholder equity of NT$243.6M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$299.9M and NT$56.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$230.42m |
| Equity | NT$243.65m |
| Total liabilities | NT$56.23m |
| Total assets | NT$299.88m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6610's short term assets (NT$231.8M) exceed its short term liabilities (NT$49.2M).
Long Term Liabilities: 6610's short term assets (NT$231.8M) exceed its long term liabilities (NT$7.0M).
Debt to Equity History and Analysis
Debt Level: 6610 is debt free.
Reducing Debt: 6610 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6610 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6610 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1% each year